This Article Full Text Full Text (PDF) All Versions of this Article: 37/2/513    most recent 01.STR.0000198826.56611.a2v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saito, A. Articles by Chan, P. H. Search for Related Content PubMed PubMed Citation Articles by Saito, A. Articles by Chan, P. H. Related Collections Apoptosis Genetically altered mice Ischemic biology - basic studies

(Stroke. 2006;37:513.)
© 2006 American Heart Association, Inc.

Original Contributions

Modulation of Proline-Rich Akt Substrate Survival Signaling Pathways by Oxidative Stress in Mouse Brains After Transient Focal Cerebral Ischemia

Atsushi Saito, MD; Takeshi Hayashi, MD, PhD; Shuzo Okuno, MD; Tatsuro Nishi, MD, PhD Pak H. Chan, PhD

From the Department of Neurosurgery, Department of Neurology and Neurological Sciences, and Program in Neurosciences, Stanford University School of Medicine, California.

Correspondence to Dr Pak H. Chan, Neurosurgical Laboratories, Stanford University, 1201 Welch Rd, MSLS#P314, Stanford, CA 94305-5487. E-mail phchan{at}stanford.edu

Background and Purpose— A proline-rich Akt substrate (PRAS) contributes to the regulation of apoptosis after a variety of cell death stimuli, as well as in an in vivo transient focal cerebral ischemia (tFCI) model. We reported previously that overexpression of copper/zinc-superoxide dismutase (SOD1) reduces apoptotic cell death after tFCI. Our present study was designed to clarify the relationship between the PRAS signaling pathway and oxidative stress in the regulation of apoptosis after tFCI.

Methods— We used a tFCI model with SOD1 transgenic mice and wild-type littermates to examine the expression of phosphorylated PRAS (pPRAS) by Western blotting and immunohistochemistry and the interaction of pPRAS with phosphorylated Akt (pPRAS/pAkt) or the 14-3-3 protein (pPRAS/14-3-3) by coimmunoprecipitation. Direct oxidation of the carbonyl groups, an indication of oxidative injury to total and individual proteins caused by tFCI, was examined using a 2,4-dinitrophenylhydrazone reaction assay.

Results— Expression of pPRAS, pPRAS/pAkt, and pPRAS/14-3-3 decreased 2 hours after tFCI. Oxidized hydroethidine did not colocalize with expression of pPRAS. Individual oxidized carbonyls in pPRAS remarkably increased 2 hours after tFCI but were significantly reduced by SOD1 2 hours after tFCI. Expression of pPRAS, pPRAS/pAkt, and pPRAS/14-3-3 was promoted by SOD1 during the same time course.

Conclusions— These results suggest that overexpression of SOD1 may affect the PRAS pathway after tFCI by reducing the direct oxidative reaction to pPRAS after reperfusion injury.

Key Words: apoptosis • cerebral ischemia

This article has been cited by other articles:

				N. Oshiro, R. Takahashi, K.-i. Yoshino, K. Tanimura, A. Nakashima, S. Eguchi, T. Miyamoto, K. Hara, K. Takehana, J. Avruch, et al. The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1 J. Biol. Chem., July 13, 2007; 282(28): 20329 - 20339. [Abstract] [Full Text] [PDF]

				S. V. Madhunapantula, A. Sharma, and G. P. Robertson PRAS40 Deregulates Apoptosis in Malignant Melanoma Cancer Res., April 15, 2007; 67(8): 3626 - 3636. [Abstract] [Full Text] [PDF]